Presentations for the May 18, 2017 Meeting of the Pediatric Advisory Committee and the Pediatric Ethics Subcommiittee
Persons with disabilities having problems accessing the PDF files below may call 240-402-3838 for assistance.
- FDA Presentation: Additional Safeguards for Children in Research and Protocol Review Under 21 CFR 50.54
- Sponsor Presentation
- Parent and Patient Presentation: The Patient and Parent Perspective
- UCLA IRB Presentation: UCLA IRB FDA Referral on the Essence Trial for Duchenne Muscular Dystrophy
- UCLA Principal Investigator Presentation: The Essence Clinical Trial: Protocol Design and Obstacles